Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy.

Herrstedt, J; Sigsgaard, T; Boesgaard, M; Jensen, T P; Dombernowsky, P

Herrstedt, J; Sigsgaard, T; Boesgaard, M; Jensen, T P; Dombernowsky, P.

Affiliation

Herrstedt J; Department of Oncology, Herlev Hospital, University of Copenhagen, Denmark.

N Engl J Med ; 328(15): 1076-80, 1993 Apr 15.

Article in En | MEDLINE | ID: mdl-8455664

Subject(s)

Antiemetics/administration & dosage; Chemotherapy, Adjuvant; Isonipecotic Acids/administration & dosage; Ondansetron/administration & dosage; Vomiting/prevention & control; Adult; Aged; Antiemetics/adverse effects; Antiemetics/therapeutic use; Breast Neoplasms/drug therapy; Double-Blind Method; Female; Humans; Isonipecotic Acids/adverse effects; Isonipecotic Acids/therapeutic use; Male; Middle Aged; Nausea/prevention & control; Ondansetron/adverse effects; Ondansetron/therapeutic use; Vomiting/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Chemotherapy, Adjuvant / Ondansetron / Isonipecotic Acids / Antiemetics Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: N Engl J Med Year: 1993 Document type: Article Affiliation country: Denmark

Search on Google

Add to My VHL

XML

PubMed Links